i currently hold 65000 shares in osmtech as anyone heard any news on what is happening with them lately ? as they do not seem to be gaining very much

i hold well in excess of 100,000 shares in this company and back it all the way i feel this company is going to grow at a nice pace in the coming 2 years what are other peoples thoughts since the results have just come out?

why is the price falling so much on this share, should be rising surely :-((

I'm happy to see this share fall...because I will be piling in.
regards

I think the fall in the share price is due to the lethargy in the stock market as a whole, I am not expecting any significant increase until there is a consistent improvement in the market generally. Have a little more patience and I believe we will be rewarded in due course.

i currently hold in excess of 100000 shares in omh and rate them 100% what are other peoples views as i feel these shares are now under priced!

I currently hold in excess of 2,000,000 shares in omh and I am not even slighty concerned about this short term drop. Read the results digest what is going on.
This is a post from III which I think nicely sums up the current position.


Author B0l0l
Date posted Sunday 22:18
Classification Answer
Subject: Re: OMH in profit View parent message
Opinion Strong BUY
Recommendations This message has been recommended 8 times
Message

EVO and co are predicting 2007 (for profitability). Personally I think that is bollox and is probably just another one of their games to help keep the share price low. EVO have called it wrong by a significant amount for both previous sets of results so I would take any predication they make as the worst possible scenario.

VIP is on target to launch during 2005 in to a vast multi billion dollar market. James White has said that the company should start to see some substantial benefit from the IDEXX deal late 2004. The company have said that just one of the IDEXX deals could see the number of OPTI machines in use double. The ComfortSampler could do $1m-$2m sales within 2-3 years alone. Starting to see the picture yet?

Year end 2003 the company had 3,238,833 in the bank. Year end 2004 the company still had 3,172,317 mln in the bank.

The company has managed to launch three new products, continued to develop VIP and the new OPTI machines and has only had to spend 36,526 of its cash reserve to achieve this.

It is far more sensible at this stage for the company to reinvest the profits from OPTI heavily in R&D and continue to show a loss rather than declaring a taxable profit just to appease impatient shareholders. Its far better to accrue tax losses now to offset against future profits.

Before we move in to profit which I estimate could be by early 2006, my guess is that we will see another share issue similar to the one last October to finance another acquisition. This is why I think EVO are working overtime to keep the share price in its current trading range. After the acquisition there will be a share consolidation which will more the company out of penny status and put it back on the radar of the institutions. After that a move back to the main index and possible a listing in the US.
Any one else care to speculate?

Bol

Ditchpig

Everything this company is doing appears to be spot on, medium to long term the SP will reflect their efforts and reward the shareholders. Companies that are producing good results, without a hike in the SP seem to be ten a penny at the moment. Becoming my mantra, but patience is the key.

regards

PTH

Investors Chronical :-

Osmetech has totally changed since making last year's acquisition of Roche's OPTI blood-gas analyser business. Run by chief executive James White, Osmetech used to be something of a 'jam tomorrow' proposition, developing its enose diagnostic product for vaginal infections. However, Osmetech now has a salesforce and revenues.
The enose product, now known as VIP, is awaiting approval by the US Food and Drug Administration ahead of its launch in 2005. But there should be plenty of demand given that the rise in sexually transmitted diseases, such as Chlamydia, is still an issue and is likely to remain so for the foreseeable future. Osmetech plans to distribute the product through its own salesforce.
Meanwhile, its OPTI business benefited from 1m in one-off Sars-related sales to China, and the company is to launch five new products this year. Its new critical-care analyser was successfully unveiled at the American Association of Clinical Chemists Conference. Osmetech has also signed a manufacturing and distribution deal with US animal health diagnostics company IDEXX. Mr White is looking out for further potential product or company acquisitions in the OPTI mould. House broker Evolution Beeson Gregory forecasts pre-tax losses of 2.1m for 2005.


IC View: Osmetech remains loss-making, but claims it has enough cash to last until it reaches profitability. With the revenues from OPTI, potential upside from the IDEXX deal, and next year's launch of VIP, 2005 looks promising. Good value.

I've held this stock for over 4 years now; still have the 1024 shares I purchased at 27 pence or very near.

Went in again last Autumn for about 4.05 pence for 50,000 shares, and will go in again for some more today.

Lets get everything into perspective here.......
These guys (if indeed it all works out) will not only make millions on sales across varying markets (Sars/Medical/Veterinary & Explosive testing equipment)but just for the vaginal smear product alone, they will save the industry many more millions.

That product alone will return instant medical results, thus knocking weeks off testing samples, which will save even more money and of course lives.

I say Buy and Hold fast - it was money we were willing to believe in once and I say stick with this market. Medical will always have to improve.

will do very well if survive next 3months

jadedhills
It is totally uninformed comments that panics smaller investors and causes large swings in prices. This is a well managed company that is is now making PROFITS. It has bought two companies over the past two years which have been superb buys and have proved to be profit enhancing immediatly. What more can the directors do to prove to numbskulls like you that you are missing a golden opportunity.

patience is all that is needed with this company all us share holders have had a bumpy ride but those that buy in now and stay in at these prices will be highly rewarded in i would say 18 months time i my self am more than happy to see the price fall even lower than the price is now i simply use this as a means to lower my average down a add to already nice holding if u cant take the heat with this one then i suggest a more stable stock like RSA etc.
best of look to all who hold this stock but bewarned this wont stay at this price for ever and when the market catches up you will never see these prices again have a look at GMC and see what i mean!!!!

I have held these for longer than I care to remember, must say I now feel more confident than ever.
Will hold however long it takes and that might be sooner than later.
I seem to remember that it was thought these were worth about 7p and that was before this latest tranch of news.Can't print what I think of MM's, I would never be allowed to post again.( make a fair market in a company,Bah,Bah).

Jadedhills,
The last set of company accounts showed sufficient funding to carry the company for two years. Since then we have had the licencing deal with Roche for the use of the companys proprietary plastic tube technology. We've had a minor deal with AVOX which has allowed Osmo to become world wide distrbutor(USA excluded) of the AVOX4000. We've had the news that in addition IDEXX's requirements for the Osmetech Vetstat, an additional 450 Vetstat machines are required to go in to one of the leadng US animal hospital chains oh and the news that sales have now passed the $10 million dollar mark.
In the coming months we will have the launch of two new OPti-Blood products and the worldwide unveiling of OPTI-Gene in November.
I somehow suspect that surviving the next 3 months will not cause that much of a problem.

Found out today they are listed on the Berlin Boerse probably for the shorters over there probably not helping the share price.IMHO.